- Home
- NFJ vs BLFS Comparison
NFJ vs BLFS Comparison
Compare NFJ & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFJ
- BLFS
- Stock Information
- Founded
- NFJ 2005
- BLFS 1987
- Country
- NFJ United States
- BLFS United States
- Employees
- NFJ N/A
- BLFS N/A
- Industry
- NFJ Finance: Consumer Services
- BLFS Medical/Dental Instruments
- Sector
- NFJ Finance
- BLFS Health Care
- Exchange
- NFJ Nasdaq
- BLFS Nasdaq
- Market Cap
- NFJ 1.1B
- BLFS 1.1B
- IPO Year
- NFJ N/A
- BLFS 1989
- Fundamental
- Price
- NFJ $12.03
- BLFS $21.22
- Analyst Decision
- NFJ
- BLFS Strong Buy
- Analyst Count
- NFJ 0
- BLFS 7
- Target Price
- NFJ N/A
- BLFS $30.57
- AVG Volume (30 Days)
- NFJ 223.5K
- BLFS 565.5K
- Earning Date
- NFJ 01-01-0001
- BLFS 08-07-2025
- Dividend Yield
- NFJ 9.01%
- BLFS N/A
- EPS Growth
- NFJ N/A
- BLFS N/A
- EPS
- NFJ N/A
- BLFS N/A
- Revenue
- NFJ N/A
- BLFS $87,762,000.00
- Revenue This Year
- NFJ N/A
- BLFS $21.21
- Revenue Next Year
- NFJ N/A
- BLFS $17.58
- P/E Ratio
- NFJ N/A
- BLFS N/A
- Revenue Growth
- NFJ N/A
- BLFS 34.80
- 52 Week Low
- NFJ $10.45
- BLFS $18.70
- 52 Week High
- NFJ $12.86
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- NFJ 49.21
- BLFS 41.52
- Support Level
- NFJ $12.00
- BLFS $21.76
- Resistance Level
- NFJ $12.19
- BLFS $22.76
- Average True Range (ATR)
- NFJ 0.13
- BLFS 1.14
- MACD
- NFJ -0.04
- BLFS -0.11
- Stochastic Oscillator
- NFJ 11.76
- BLFS 22.41
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.